Persons with obesity and type 2 diabetes have lower mucosal IgA and pharmacological therapies for diabetes such as metformin and bariatric surgery increase cellular and stool IgA levels [32,33]. This evidence concerns the gene CD79A and obesity due to melanocortin 4 receptor deficiency.